| Pyruvate therapy for Leigh syndrome due to cytochrome c oxidase deficiency. | |
| | |
MedLine Citation:
|
PMID: 19616603 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Recently we proposed the therapeutic potential of pyruvate therapy for mitochondrial diseases. Leigh syndrome is a progressive neurodegenerative disorder ascribed to either mitochondrial or nuclear DNA mutations. METHODS: In an attempt to circumvent the mitochondrial dysfunction, we orally applied sodium pyruvate and analyzed its effect on an 11-year-old female with Leigh syndrome due to cytochrome c oxidase deficiency accompanied by cardiomyopathy. The patient was administered sodium pyruvate at a maintenance dose of 0.5 g/kg/day and followed up for 1 year. RESULTS: The exercise intolerance was remarkably improved so that she became capable of running. Echocardiography indicated improvements both in the left ventricle ejection fraction and in the fractional shortening. Electrocardiography demonstrated amelioration of the inverted T waves. When the pyruvate administration was interrupted because of a gastrointestinal infection, the serum lactate level became elevated and the serum pyruvate level, decreased, suggesting that the pyruvate administration was effective in decreasing the lactate-to-pyruvate ratio. CONCLUSIONS: These data indicate that pyruvate therapy was effective in improving exercise intolerance at least in a patient with cytochrome c oxidase deficiency. GENERAL SIGNIFICANCE: Administration of sodium pyruvate may prove effective for other patients with cytochrome c oxidase deficiency due to mitochondrial or nuclear DNA mutations. |
| | |
Authors:
|
Hirofumi Komaki; Yutaka Nishigaki; Noriyuki Fuku; Hiroko Hosoya; Kei Murayama; Akira Ohtake; Yu-Ichi Goto; Hiroyuki Wakamoto; Yasutoshi Koga; Masashi Tanaka |
Related Documents
:
|
11834113 - Blood lactate and stroke parameters during front crawl in elite swimmers with disability. 8262703 - Performance and blood lactate on gjessing and concept ii rowing ergometers. 1223313 - Sex therapy and mastectomy. |
Publication Detail:
|
Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't Date: 2009-07-17 |
Journal Detail:
|
Title: Biochimica et biophysica acta Volume: 1800 ISSN: 0006-3002 ISO Abbreviation: Biochim. Biophys. Acta Publication Date: 2010 Mar |
Date Detail:
|
Created Date: 2010-02-22 Completed Date: 2010-05-03 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0217513 Medline TA: Biochim Biophys Acta Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 313-5 Citation Subset: IM |
Copyright Information:
|
Copyright (c) 2009 Elsevier B.V. All rights reserved. |
Affiliation:
|
Department of Pediatric Neurology, National Center Hospital of Neurology and Psychiatry, Kodaira, Tokyo 187-8502, Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Cytochrome-c Oxidase Deficiency / genetics* DNA / genetics DNA, Mitochondrial / genetics Electron Transport Complex IV / genetics* Female Humans Leigh Disease / drug therapy*, enzymology, genetics*, pathology Magnetic Resonance Imaging Mutation Nystagmus, Pathologic / genetics, pathology Pyruvates / therapeutic use* |
| Chemical | |
Reg. No./Substance:
|
0/DNA, Mitochondrial; 0/Pyruvates; 9007-49-2/DNA; EC 1.9.3.1/Electron Transport Complex IV |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Functional complementation of mitochondrial DNAs: Mobilizing mitochondrial genetics against dysfunct...
Next Document: Proton motive force dissipation precludes interaction of microcin J25 with RNA polymerase, but enhan...